Stratification [resa]
Cardiovascular disease [dsyn]
Primary Prevention [topp]
scoring [qnco]
System [ftcn]
Novel [tmco]
Marker [clna]
Imaging Techniques [diap]
Paper [mnob]
Current [tmco]
Methods [inpr]
Stratification [resa]
Cardiovascular disease [dsyn]
Prevention [topp]
Biomarkers [clna]
Imaging Techniques [diap]
Relative [famg]
limitations [ftcn]
Report [inpr]
Based [ftcn]
discussions [topp]
Take [hlca]
Place [spco]
Area [geoa]
Special [qlco]
CARDIOVASCULAR [bdsy]
Workshop [edac]
Organized [ftcn]
European [popg]
society [orgt]
Cardiology [bmod]
Working Group [popg]
Cardiovascular Pharmacology [bmod]
Drug Therapy [topp]
Classical [qlco]
risk factors [qnco]
Blood Pressure [orgf]
Low density lipoprotein cholesterol level [lbpr]
estimation [menp]
Primary Prevention [topp]
Guide [prog]
Management [ocac]
Limited [ftcn]
Several [qnco]
thresholds [qlco]
Drug [phsu]
treatment [ftcn]
Available [ftcn]
Cost Effectiveness [qnco]
benefit risk [qlco]
Ratio [qnco]
Assessment [hlca]
IMPRECISION [phpr]
III [inpr]
Residual [qlco]
effective [qlco]
Dyslipidaemia [dsyn]
Hypertension [dsyn]
Novel [tmco]
Measures [qnco]
C-reactive protein [aapp, imft]
Lipoprotein-Associated Phospholipase A2 [aapp, enzy]
Genetic Markers [genf]
Marker [clna]
Subclinical [qlco]
Organ [bpoc]
Damage [inpo]
Levels [qlco]
High resolution [lbpr]
Ultrasound [diap]
Magnetic Resonance Imaging [diap]
Carotid [bpoc]
atherosclerotic [ftcn]
Validation [resa]
Standardization [resa]
General Population [popg]
Classical [qlco]
scoring [qnco]
System [ftcn]
Available [ftcn]
limitations [ftcn]
Novel [tmco]
Markers, Risk [qlco]
Imaging Techniques [diap]
Place [spco]
Drug Development [bmod]
Clinical Trial [resa]
Design [acty]
Additional [ftcn]
Value [qnco]
Classical [qlco]
risk factors [qnco]
Guide [prog]
therapy [ftcn]
Cardiovascular disease [dsyn]
Prevention [topp]
